Acción 300119 TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tianjin Ringpu Bio-Technology Co.,Ltd.

Acciones

300119

CNE100000TV1

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 27/06/2024 		Varia. Cinco días. Varia. 1 de enero.
13,66 CNY -1,94 % Gráfico intradía de Tianjin Ringpu Bio-Technology Co.,Ltd. -3,12 % -16,66 %
29/04 Tianjin Ringpu Bio-Technology Co.,Ltd. Ltd. (SZSE:300119) completó la adquisición de Baoding Shoujun Technology Co., Ltd. a Yao Lili, Zhang Xiaoqin y Tianjin Ruichuang Biotechnology Partnership (Sociedad Limitada). CI
25/04 Tianjin Ringpu Bio-Technology Co.,Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Tianjin Ringpu Bio-Technology Co.,Ltd. Implements Cash Dividend on A Shares for 2023, Payable on 15 May 2024
Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership).
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million.
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300119
  4. Noticias Tianjin Ringpu Bio-Technology Co.,Ltd.
  5. Otros idiomas